Development of a single-chain fragment variable fused-mutant HALT-1 recombinant immunotoxin against G12V mutated KRAS colorectal cancer cells
Background: KRAS oncogenes harboring codon G12 and G13 substitutions are considered gatekeeper mutations which drive oncogenesis in many cancers. To date, there are still no target-specific vaccines or drugs available against this genotype, thus reinforcing the need towards the development of target...
Saved in:
Main Authors: | Teo, Michelle Yee Mun, Ng, Jeremy Jeack Ceen, Jung, Yin Fong, Jung, Shan Hwang, Song, Adelene Ai Lian, Lim, Renee Lay Hong, In, Lionel Lian Aun |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Publishing
2021
|
Online Access: | http://psasir.upm.edu.my/id/eprint/96690/1/ABSTRACT.pdf http://psasir.upm.edu.my/id/eprint/96690/ https://peerj.com/articles/11063/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of secretion efficiency of mutant KRAS neoantigen by Lactococcus lactis on the immune response of a mucosal vaccine delivery vehicle targeting colorectal cancer
by: Alias, Nur Aqlili Riana, et al.
Published: (2023) -
In silico-guided sequence modifications of K-ras epitopes improve immunological outcome against G12V and G13D mutant KRAS antigens
by: Wee, Allan Ren Ng, et al.
Published: (2018) -
Is Proteolytic Cleavage Essential for the Enhanced Activity of Hydra Pore-Forming Toxin, HALT-4?
by: Yap, Wei Yuen *, et al.
Published: (2023) -
Association between autophagy and KRAS mutation with
clinicopathological variables in colorectal cancer patients
by: Awi, Noel Jacques, et al.
Published: (2021) -
Enhanced production of recombinant HALT-1 pore-forming toxin using two-step chromatographic procedure
by: Yap, Wei Yuen *, et al.
Published: (2023)